Cargando…
Left Atrial Functional Remodeling in Patients with Chronic Heart Failure Treated with Sacubitril/Valsartan
(1) Background: Previous studies showed left ventricular (LV) and left atrial (LA) improvement and reverse remodeling after therapy with Sacubitril/Valsartan (S/V) in patients affected by heart failure with reduced ejection fraction (HFrEF). Therefore, we sought to investigate predictors of LA struc...
Autores principales: | Correale, Michele, Magnesa, Michele, Mazzeo, Pietro, Fortunato, Martino, Tricarico, Lucia, Leopizzi, Alessandra, Mallardi, Adriana, Mennella, Raffaele, Croella, Francesca, Iacoviello, Massimo, Di Biase, Matteo, Brunetti, Natale Daniele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917469/ https://www.ncbi.nlm.nih.gov/pubmed/36769734 http://dx.doi.org/10.3390/jcm12031086 |
Ejemplares similares
-
Predictors of right ventricular function improvement with sacubitril/valsartan in a real‐life population of patients with chronic heart failure
por: Correale, Michele, et al.
Publicado: (2021) -
The Evolving Phenotypes of Cardiovascular Disease during COVID-19 Pandemic
por: Correale, Michele, et al.
Publicado: (2021) -
Sacubitril/valsartan improves right ventricular function in a real-life population of patients with chronic heart failure: The Daunia Heart Failure Registry
por: Correale, Michele, et al.
Publicado: (2020) -
Switch to SGLT2 Inhibitors and Improved Endothelial Function in Diabetic Patients with Chronic Heart Failure
por: Correale, Michele, et al.
Publicado: (2021) -
Effects of Sacubitril/Valsartan on the Renal Resistance Index
por: Gioia, Margherita Ilaria, et al.
Publicado: (2022)